We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
-5.16%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$391M
AUM Growth
-$24.4M
Cap. Flow
+$3.56M
Cap. Flow %
0.91%
Top 10 Hldgs %
39.51%
Holding
78
New
4
Increased
33
Reduced
22
Closed
3

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$14.4M
2
MDT icon
Medtronic
MDT
+$2.11M
3
EW icon
Edwards Lifesciences
EW
+$1.58M
4
AMZN icon
Amazon
AMZN
+$1.58M
5
APTV icon
Aptiv
APTV
+$1.17M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$14.9M
2
BDX icon
Becton Dickinson
BDX
+$4.21M
3
UL icon
Unilever
UL
+$3.87M
4
MMM icon
3M
MMM
+$481K
5
AAPL icon
Apple
AAPL
+$478K

Sector Composition

Rank Sector Weight
1 Technology 24.71%
2 Healthcare 22.08%
3 Industrials 13.04%
4 Consumer Discretionary 8.18%
5 Communication Services 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
26
Illumina
ILMN
$29.8B
$5.34M 1.36%
15,708
+334
+2% +$113K
XYL icon
27
Xylem
XYL
$27.8B
$5.31M 1.36%
62,309
+691
+1% +$66.2K
NKE icon
28
Nike
NKE
$60.8B
$4.9M 1.25%
36,430
+1,424
+4% +$200K
EW icon
29
Edwards Lifesciences
EW
$48.3B
$4.88M 1.25%
41,483
+14,066
+51% +$1.58M
CVX icon
30
Chevron
CVX
$387B
$4.49M 1.15%
27,575
+84
+0.3% +$12K
PEP icon
31
PepsiCo
PEP
$184B
$4.01M 1.02%
23,945
-123
-0.5% -$20.7K
NVS icon
32
Novartis
NVS
$297B
$3.18M 0.81%
36,233
-4,867
-12% -$421K
XOM icon
33
ExxonMobil
XOM
$650B
$2.99M 0.76%
36,174
-130
-0.4% -$10.1K
CHD icon
34
Church & Dwight Co
CHD
$22.8B
$2.78M 0.71%
27,958
+9,970
+55% +$993K
ABBV icon
35
AbbVie
ABBV
$454B
$2.48M 0.63%
15,312
-590
-4% -$85.7K
APTV icon
36
Aptiv
APTV
$11.9B
$2.33M 0.59%
19,430
+8,768
+82% +$1.17M
MDT icon
37
Medtronic
MDT
$105B
$2.21M 0.57%
+19,969
New +$2.11M
SPTM icon
38
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.4B
$1.67M 0.43%
30,000
-3,600
-11% -$197K
WELL icon
39
Welltower
WELL
$174B
$1.44M 0.37%
15,000
+5,090
+51% +$442K
INTC icon
40
Intel
INTC
$504B
$1.39M 0.35%
27,965
-5,990
-18% -$297K
IRWD icon
41
Ironwood Pharmaceuticals
IRWD
$624M
$1.21M 0.31%
96,000
-6,946
-7% -$79.6K
BDX icon
42
Becton Dickinson
BDX
$42.1B
$1.2M 0.31%
4,603
-16,364
-78% -$4.21M
MMM icon
43
3M
MMM
$87.5B
$1.07M 0.27%
8,605
-3,618
-30% -$481K
UL icon
44
Unilever
UL
$130B
$882K 0.23%
17,187
-69,443
-80% -$3.87M
BMY icon
45
Bristol-Myers Squibb
BMY
$126B
$854K 0.22%
11,700
– –
PBA icon
46
Pembina Pipeline
PBA
$29.8B
$844K 0.22%
22,428
– –
UNP icon
47
Union Pacific
UNP
$181B
$763K 0.19%
2,794
-15
-0.5% -$3.79K
TMO icon
48
Thermo Fisher Scientific
TMO
$213B
$635K 0.16%
1,075
– –
TT icon
49
Trane Technologies
TT
$106B
$606K 0.15%
3,970
– –
NVO
50
Novo Nordisk
NVO
$213B
$533K 0.14%
9,600
-370
-4% -$19K
1
2
3

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Brian C. Broderick's Q1 2022 Portfolio in Review

As of Q1 2022, Brian C. Broderick held 78 positions worth $391M, down 5.9% from $416M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Brian C. Broderick's Q1 2022 filing shows 4 new, 33 increased, 22 reduced and 3 closed positions. Its largest new stake was Advanced Micro Devices: 120,415 shares worth $13.2M. The largest sale was Xilinx Inc, an estimated $14.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q1 2022 buy was Advanced Micro Devices: 120,415 shares worth $13.2M.
  • Brian C. Broderick added most to Edwards Lifesciences in Q1 2022, an estimated $1.58M increase.
  • Brian C. Broderick's biggest Q1 2022 reduction was Becton Dickinson, cutting an estimated $4.21M.
  • Brian C. Broderick fully exited Xilinx Inc in Q1 2022, selling an estimated $14.9M.
  • Brian C. Broderick's ten largest holdings make up 40% of its $391M portfolio in Q1 2022.
  • Brian C. Broderick opened 4 new positions and closed 3 in Q1 2022.
  • Brian C. Broderick's portfolio value fell 5.9% quarter-over-quarter to $391M.

Based on Brian C. Broderick's 13F filing for Q1 2022, filed 17 May 2022.